Edna Constanza Gómez Victoria

Edna Constanza Gómez Victoria

Auto-generated profile, based on publicly available information

Edna Constanza Gómez Victoria

Departamento de Patologia Geral, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG. Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2017 in Current Neurovascular Research
Verified
Journal Article
Closed access
PDF file
EVEdna Constanza Gómez Victoria
Edna Constanza Gómez Victoria
ETEliana Toscano
Eliana Toscano
ACAna Clara de Sousa Cardoso
Ana Clara de Sousa Cardoso
DSDaniele Gonçalves da Silva
Daniele Gonçalves da Silva
AMAline Silva de Miranda
Aline Silva de Miranda
MRMilene Alvarenga Rachid
Milene Alvarenga Rachid
Background: Stroke is the second leading cause of death and a major cause of disability of adults worldwide. Inflammatory processes are known to contribute to the pathophysiology of cerebral ischemia, especially following reperfusion. Chemokines and their receptors are involved in migration of leukocytes and have been implicated in the pathogenesis of ischemic stroke. Objective: In the present study, we investigated the effects of C-C chemokine receptor type 5 (CCR5) deficiency on neurological outcome, brain damage and expression of pro-inflammatory chemokines: chemokine (C-X-C motif) ligand 1 (CXCL1), chemokine (CC motif) ligand 3 (CCL3) and chemokine (C-C motif) ligand 5 (CCL5), and the brain-derived neurotrophic factor (BDNF). Methods: Adult male C57BL/6 (wild-type) (WT) and CCR5 deficient mice were subjected to transient cerebral ischemia induced by 25 min of bilateral common carotid artery occlusion (BCCAO) followed by 24 hours of reperfusion. Mice were divided into four groups: WT sham group, which underwent sham operation; WT ischemic group, which was subjected to transient bilateral common carotid artery occlusion, CCR5-/- sham group, which underwent sham operation, and CCR5-/- ischemic group, which was subjected to transient BCCAO. Results: In CCR5 deficiency, we observed a significant improvement in the neurological deficits associated with decreased brain infarcted area as evaluated by triphenyltetrazolium chloride (TTC). Moreover, CCR5 deficiency revealed decreased percentage of necrotic cavities areas and frequency of ischemic neurons by histometric analysis. In addition, CCR5-/- ischemic animals showed lower brain levels of the chemokine CXCL1 and higher levels of BDNF by ELISA, compared with WT BCCAo mice. Conclusion: Taken together, our results suggest a potential neuroprotection in the absence of CCR5 receptor during global brain ischemia and reperfusion injury.

1 June 2016 in Brain Research Bulletin
Verified
Journal Article
Closed access
ETEliana Toscano
Eliana Toscano
BSBruno Costa Silva
Bruno Costa Silva
EVEdna Constaza Gómez Victoria
Edna Constaza Gómez Victoria
ACAna Clara de Souza Cardoso
Ana Clara de Souza Cardoso
AMAline Silva de Miranda
Aline Silva de Miranda
MRMilene Alvarenga Rachid
Milene Alvarenga Rachid